A new polymorphism in the factor VIII gene for prenatal diagnosis of hemophilia A.

AUTOR(ES)

Wion, K L

RESUMO

A restriction fragment length polymorphism (RFLP) has been found in the gene for clotting factor VIII. Defects in this gene are the cause of hemophilia A. The DNA polymorphism affects an XbaI site in intron 22 of the gene. Two alleles occur in a frequency of 59 and 41 percent of the X chromosomes tested. Furthermore, about 25 percent of females who are homozygous for the previously reported BclI RFLP in the factor VIII gene are heterozygous for the XbaI polymorphism. This new RFLP thus represents a significant addition to available probes for the DNA-based prenatal diagnosis and carrier detection of this disease.

Documentos Relacionados

• Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
• Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families.
• Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.
• The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion
• A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequences.